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A Comparison of Clinical and Judicial
Procedures for Reviewing Requests for




The Rivers v. Katz decision sub-
stituted judicial review for ad-
ministratii review of requests for
involuntary medication of patients
in New York State mental hospi-
tals. Thischange,prompted by con-
cernfor the rights of involuntarily
committedpatients, did not delay
ordiminish the use of involuntary
medication in a large state bos-
pital. Advantages ofjudicial re-
view include a better understand-
ing by clinicians oftbe legal basis
f or involuntary medication and
greater patient participation in
the review procedure. Disadvan-
tages indude lack ofan independ-
ent clinical review and increased
costs.
Two prominent issues at the inter-
face of psychiatry and the law are
the patient’s right to refuse treat-
ment and the procedures hospitals
use to obtain authorization for in-
voluntary medication (1-4). To de-
cide these issues, New York State
had relied on a clinical administra-
tive review process (5) until June
10, 1986, when, in a decision
known as Rivers v. Katz (6), the
New York State Court of Appeals
unanimously overturned this pro-
cedure. The court ruled that a
judicial hearing would be required
to determine if a patient in a state
mental hospital should be forcibly
medicated with antipsychotic
drugs. This ruling was interpreted
to apply to other types of psychi-
atnic inpatient settings and treat-
ments.
There have been many papers
discussing the right to refuse treat-
ment. As Appelbaum and Hoge
(7) point out, however, in their
extensive review of published and
unpublished papers on the topic,
systematic studies have been rare.
Most studies have looked at the
characteristics of patients who re-
fuse treatment (7-1 1). The impact
of different systems of review has
not been explored in depth, al-
though, regardless of the proce-
dure, treatment refusals appear to
be overridden 67 percent to 100
percent ofthe time (7,12,13). This
study examined the impact of the
Rivers decision at a large state hos-
pital.
Before the Rivers decision
Before Rivers, the treating physi-
cian initiated the application for
involuntary treatment. The patient
was entitled to an appeal at each
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of three ascending levels of author-
ity: the head of the service, the
facility director, and the regional
director within the state Office
of Mental Health (5). In practice,
if any of these officials were not
physicians, the review was done
by a designated physician. The regu-
lations did not specify the nature
of the review. The treating psy-
chiatnist usually submitted a psy-
chiatric summary that included the
patient’s psychiatric history, the
reasons for the current hospitali-
zation, the results of a mental
status examination, the patient’s
diagnosis, and a brief statement
about the treatment being re-
quested, in addition to the justifi-
cation for requesting involuntary
treatment. The head of the serv-
ice and the facility director or their
designees wrote brief corroborat-
ing statements. At the regional
office an independent psychiatrist
reviewed the material, raised ques-
tions if necessary, and prepared a
simple statement approving or de-
nying the request.
Additionally, New York State
provides free legal representation
to patients through the Mental
Health Legal Service (MHLS). The
head of the service was obligated
to notify MHLS when an applica-
tion for involuntary medication was
made.
Rivers v. Katz
The court in Rivers v. Katz deter-
mined that New York State’s ad-
ministrative review procedure did
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not sufficiently protect the due
process rights of involuntarily com-
mined patients. Specific inadequa-
cies of the procedure included the
lack of standards for choosing medi-
cation and for determining the du-
ration of involuntary treatment.
The court noted the long-
recognized distinction (14) be-
tween police power, the state’s
right to respond immediately to
imminent danger, and parens pa-
triae power, the state’s obligation
to care for persons who are inca-
pable of caring for themselves. The
court required that whenever the
forcible administration of antipsy-
chotic drugs was based on the ex-
ercise of parens patriae power, the
decision would be made by judi-
cial review.
The court emphasized that the
forcible administration of antipsy-
chotic drugs could occur only if
the patient lacked the capacity to
make a reasoned decision about
the proposed treatment. If the pa-
tient lacked such capacity, the
court was then directed to deter-
mine “whether the proposed treat-
ment is narrowly tailored to give
substantive effect to the patient’s
liberty interest, taking into con-
sideration all relevant circum-
stances, including the patient’s best
interests, the benefits to be gained
from the treatment, the adverse
side effects associated with the
treatment, and any less intrusive
alternative treatments” (6).
After the Rivers decision
After Rivers, a modified clinical
administrative procedure contin-
ued to be required before the
court hearing (15). New regula-
tions reduced the number of nec-
essay clinical evaluators from four
to two-the treating physician and
the clinical director or designee.
The Mental Health Legal Service
remained available to represent the
patient.
The new procedure required
each of the two evaluating psy-
chiatnists to interview the patient
personally. At state hospitals, psy-
chiatrists were required by policy
to complete an eight-page form
that included a psychiatric sum-
may, a proposed course of treat-
ment, a formal evaluation of the
patient’s capacity, and documenta-
tion that the patient had received
an explanation of the proposed
treatment. The hospital then had
to file four separate legal docu-
ments with the court, and the case
was brought to a hearing.
Method
This study examined the impact
of the Rivers decision on one state
hospital, Manhattan Psychiatric Cen-
ten. The center has approximately
1,200 beds and is one offive large
adult state hospitals in New York
City. Among these hospitals, Man-
hattan Psychiatric Center ac-
counted for 42 percent of the in-
voluntary treatment decisions in
1985.
We sought to discover if the
more intricate procedure initiated
after the Rivers decision discour-
aged clinicians from applying to
medicate patients involuntarily or
delayed treatment. Additionally we
examined whether the types of
patients selected for involuntary
treatment changed after the new
procedure was implemented and
if judges were more likely than
clinicians to uphold the patient’s
refusal.
Data were collected by review-
ing all documents generated by
the involuntary treatment proce-
dures, including clinical evalu-
ations, patients’ statements, legal
opinions, notes of court hearings,
and final outcome reports. These
documents were supplemented
with information from the state
Office of Mental Health’s com-
putenized patient information sys-
tem and from patients’ charts. The
study compared data collected for
a 12-month period from January
1 to December 3 1, 1985, with
data collected for the 1 2-month
period following implementation
of the new procedure, August 8,
1986, to August 7, 1987.
Two of the authors were di-
rectly involved with the review
process. One (FC) had been desig-
nated by the regional director to
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make the final decisions for all
cases processed in 1985. The other
author (CA) was the coordinator
of patient legal affairs for Manhat-
tan Psychiatric Center, and, after
Rivers, she was responsible for re-
viewing the adequacy of all legal
documents and filing them with
the court, scheduling hearings, and
notifying the physician, patient, and
MHLS of the count date. In addi-
tion, she also attended every hear-
ing. The third author (KM), who
had no direct involvement in the
review process, was responsible
for gathering and scoring the data.
Results
Cases approved
There was no significant differ-
ence in the number of cases proc-
essed or approved before and aS-
ten the Rivers decision. A total of
42 cases were decided during the
two periods. Of the 2 1 cases com-
pleted in 1985, 20 were approved
and one was denied. In the 1986-
87 post-Rivers period, 2 1 cases
were decided, of which 18 were
approved and three denied. The
denial in the pre-Rivers period and
one of the three denials in the
post-Rivers period were based on
insufficient clinical justification. Pro-
cedural errors in the applications
prevented the judge from decid-
ing the other two cases denied in
the post-Rivers period. One of
these cases was returned to court
following the study, and medica-
tion was approved. These results
demonstrate that the new proce-
dure did not have a significant
effect on the frequency of requests
for and approval of involuntary
treatment.
There were no significant demo-
graphic differences between the
pre-Rivers and post-Rivers groups
of patients. Patients were similar
in age, sex, ethnicity, educational
background, diagnosis, and history
of hospitalization.
The average age was 5 5 for the
women and 38 for the men. Of
the 42 patients whose cases were
processed, 36 percent were fe-
male, and 64 percent were male.
The age and sex distributions were
consistent with the composition
of the total hospital population.
Fifty-seven percent of the pa-
tients were black, 26 percent were
white, 1 2 percent were Hispanic,
and 5 percent were Asian. Fifty-
five percent had at least a high
school diploma.
Sixty-four percent of the pa-
tients had a diagnosis of schizo-
phrenia; 10 percent had schizoaf-
fective disorder; 7 percent had an
affective disorder; 7 percent had
organic brain syndrome; and 7 per-
cent had atypical psychosis. Five
percent had other diagnoses.
The average number of hospi-
talizations before the current epi-
sode was 5.3. Patients in the
pre-Rivers group had been in the
hospital for an average of 22
months at the time the involuntary
treatment request was initiated. In
the post-Rivers group, patients had
been hospitalized an average of
1 1 months when involuntary treat-
ment was recommended. This trend
fell short of statistical significance
and may have been related to the
transfer of 100 long-stay patients
to other facilities between the two
study periods.
Both the clinical and the judi-
cial procedures were time-consum-
ing, but there was no significant
difference between the study pen-
ods in the average time elapsed
from the first evaluation until the
final decision. The process took
an average of 5.4 weeks under the
old procedure and 5.8 weeks un-
den the new procedure.
Reasons for
involuntary medication
Clinicians’ reasons for recommend-
ing involuntary medication fell into
five categories: risk of assault, risk
of suicide, serious untreated medi-
cal illness, severe mental illness
with regression, and severe men-
tal illness without regression. Re-
gression refers to behaviors that
interfere with self-care and includes
refusal to eat, bathe, dress, or en-
gage in minimal social interaction.
Mental illness without regression
was the only category that did not
include behavior posing a danger
to either the patient or others.
The primary reason for treat-
ment refers to the issue that re-
ceived the strongest emphasis in
the application. For the pre-Rivers
sample, the primary reasons for
requesting involuntary medication
were severe mental illness with
regression for nine of 2 1 subjects
(43 percent), risk of assault for
five patients (24 percent), serious
untreated medical illness for four
patients (19 percent), risk of sui-
cide for two patients (10 percent),
and mental illness without regres-
sion for one patient (5 percent).
For most pre-Rivers patients,
there was more than one reason
for the treatment request, and 43
percent of the sample were con-
sidered to be simultaneously re-
gressed, suicidal or assaultive, and
medically ill. In addition to refus-
ing psychotropic medication, these
patients often refused other inter-
ventions. Eighty-one percent of the
sample had episodes of refusing
physical care, including refusal of
food (29 percent), refusal to bathe
(38 percent), and refusal of medi-
cal evaluation or care (57 per-
cent).
After Rivers, the primary rea-
sons for requesting treatment were
severe mental illness with regres-
sion for seven of the 2 1 patients
(33 percent), risk of assault for six
patients (29 percent), severe men-
tal illness without regression for
six patients (29 percent), and seni-
ous untreated medical illness for
two patients ( 10 percent). Risk of
suicide was not given as a primary
reason for requesting treatment
for any of the 2 1 post-Rivers sub-
jects. However, 10 percent of the
sample were considered simulta-
neously regressed, suicidal or as-
saultive, and medically ill, and 71
percent had episodes of refusing
physical care.
The only significant difference
between the pre- and post-Rivers
samples in the primary reason for
requesting medication was the num-
ben of patients for whom the justi-
fication was mental illness without
regression. Before Rivers, there was
only one such case, and this re-
quest was denied. Of the six such
cases after Rivers, five were ap-
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proved and one denied. This dif-
ference was statistically significant
(243, df=1, p<.05).
Although the number of cases
in each sample is small, the results
suggest that clinicians were more
willing after Rivers to request in-
voluntary treatment on the basis
of serious mental illness, even if
the patients presented no risk of
harm to themselves or others. This
trend seemed to be consistent with
the court’s focus on capacity, rather
than dangerousness, in determin-
ing the appropriateness of invol-
untary treatment based on the pa-
rens patriae rationale.
Participants’ roles
Before Rivers, patients took little
part in the review procedure. The
Mental Health Legal Service, al-
though available to patients, wrote
a statement in only one of the 21
pre-Rivers cases. No patient sub-
mitted a personal statement. The
final decision was issued from a
distant administrative office.
The new procedure allows much
more interaction. The hearing
takes place on the premises of the
hospital and generally lasts 30 to
45 minutes. At least five people
are present: the judge, the Mental
Health Legal Service lawyer rep-
resenting the patient, the treating
psychiatrist, the hospital’s legal af-
fairs coordinator, and a lawyer
from the state attorney general’s
office representing the hospital.
In two of the cases in the
post-Rivers sample, an independ-
ent psychiatrist was also present.
In addition, patients are permitted
to attend the hearings, affording
them the opportunity to hear their
situations presented from the
perspective of the hospital staff.
Fifteen patients in the post-Rivers
sample came to court. Eight of
these patients testified, and five
were able to make statements rele-
vant to the treatment decision. In
the only case in which the request
for treatment was denied by a
judge on clinical grounds, the pa-
tient had come to court and had
been able to provide coherent and
relevant testimony about his wish
not to be medicated.
No MHLS lawyer argued that
patients had the capacity to make
the treatment decision. Rather,
MHLS arguments in the post-
Rivers cases focused on whether
the treatment was in the best in-
terests of the patient. Side effects
Fifteen patients in
the post-Rivers sample
came to court. Eight
of these patients
testified, and five
were able to make
statements relevant to
the treatment decision.
were mentioned as a reason to
uphold the refusal in 19 of 21
cases and were the sole reason in
1 1 cases. Less frequently men-
tioned were unresolved clinical ques-
tions, legal obstacles other than
capacity, and possible alternative
treatments.
Nine different judges decided
the 2 1 post-Rivers cases. They
played a fairly active role, asking
questions about the diagnosis in
29 percent of the cases and ques-
tioning the proposed treatment in
67 percent of the cases. Nonethe-
less, in all but one case in which
the request for treatment was ap-
proved, the judge accepted the
plan for medication exactly as out-
lined by the physician. In that
instance, the patient strongly ob-
jected to the physician’s first choice
of drug, haloperidol, because of
previously experienced side effects.
The judge ordered the use of the
physician’s second choice of medi-
cation, chlorpromazine.
Duration of treatment
The pre-Rivers regulations did not
include limits on the length of
time for which medication could
be approved. In practice, however,
the New York City regional office
routinely approved treatment for
a three-month period. Treating
staff could submit follow-up re-
ports and request treatment ex-
tensions for three-month blocks
of time. In the pre-Rivers sample,
an extension of the initial treat-
ment approval period was re-
quested for 50 percent of the pa-
tients. The average period of ap-
proval for involuntary treatment
was 6.8 months.
Under the new procedure,
judges approved involuntary treat-
ment for periods of time ranging
from 30 days to six months, with
an average of 3.7 months. How-
ever, there is no court procedure
for requesting an extension of on-
going involuntary treatment. An
entirely new application is required
to extend treatment, and the hear-
ing is scheduled with the next
available judge. It is unlikely that
this judge will be the same one
who approved the initial period
of treatment.
Partially compliant patients
The pre-Rivers procedure did not
make a distinction between pa-
tients who sometimes refuse medi-
cation and those who always re-
fuse it, and did not assess compli-
ance on the day the decision was
made. According to medication ad-
ministration records, four of the
ten pre-Rivers patients for whom
an extension of treatment was ap-
proved were more than 90 per-
cent compliant with medication at
the time of the request.
After Rivers, the judges, the law-
yers for the hospital, and the
MHLS lawyers informally decided
that the new procedure would be
used only when patients consis-
tently refused medication. The hos-
pital does not proceed if the pa-
tient is compliant on the day of
the hearing.
This change increased the num-
ber of cases scheduled for a final
review but withdrawn before this
step occurred. In the pre-Rivers
sample, clinicians withdrew one
case just before the final review
because the patient had become
compliant. After Rivers, seven cases
reached the court calendar but
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were withdrawn before the hear-
ing because the patients had be-
come totally or partially compliant
with medication.
Conclusions
Converting from a clinical admin-
istrative procedure for approving
involuntary treatment to a more
stringent legal procedure did not
delay or diminish requests for or
approval of involuntary treatment
at Manhattan Psychiatric Center.
Patients for whom involuntary treat-
ment was sought were severely
ill, frequently dangerous, and some-
times unable to accept help of any
kind. It is possible that complexity
of the procedure did not play a
role in the staffs willingness to
pursue involuntary treatment for
certain patients, because the de-
termining factor in their decision
to seek treatment was the severity
of the patients’ illness rather than
the complexity of the procedure.
The new procedure had several
advantages. It helped shift clini-
cians’ focus away from the pa-
tient’s dangerousness and onto the
patient’s capacity to make treat-
ment decisions. Although the sam-
pie of post-Rivers cases is small,
our analysis suggests that clini-
cians were more willing to seek
involuntary treatment for patients
who were neither severely dete-
riorated non dangerous.
For patients, the procedure of-
fered considerably greater repre-
sentation and participation. Al-
though most patients received treat-
ment despite their objections, they
had the opportunity to hear a de-
tailed discussion of their physician’s
reasoning and to present their own
views. Some patients may gain a
better understanding of the need
for treatment through a process
that offers this degree of patient
involvement.
The new procedure is more
costly than the pre-Rivers proce-
dune. More staff time and more
participation by personnel in the
legal system are required. Other
disadvantages include the lack of
a simple process for extending the
period of involuntary treatment
and lack of a formal procedure for
handling partially compliant pa-
tients. These last two problems
may be resolved as the procedure
is refined.
The Rivers court had hoped that
the new procedure would allow
for the establishment of legal stan-
dards for the risks, benefits, and
intrusiveness of different treat-
ments. This was not possible.
Judges do not have the expertise
to make treatment decisions and
almost always defer to physicians.
Although an independent psychia-
tnist can be called in, this rarely
occurred during the period under
study. The lack of an independent
clinical review is probably the great-
est deficiency in the new proce-
dune.
The Rivers case was brought on
behalf of patients in the state hos-
pital system, and generalization to
other settings may be problematic.
For example, an acute care unit
in a general hospital without on-
site legal services may find the
new procedure impossibly time con-
suming and complex. Considerable
frustration is likely to occur in
facilities that lack the time and
resources to carry out the post-
Rivers procedure.
Finally, the results of this study
suggest that it is more important
to focus on whether an involun-
tary treatment procedure gives ex-
pression to sound legal and clini-
cal principles than to argue over
whether physicians or courts
should be making the final deci-
sions.
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Correction
In the News & Notes section of
the July issue, the last line was
dropped from the article about
the congressional report cniticiz-
ing the funding cutbacks at the
National Institute of Mental
Health. The last sentence (on page
796) should have said that the
report called for giving NIMH
internal authority to make staffing
decisions.
